Frederick Feit, MD

  • Specialties: Interventional Cardiology, Cardiology
  • Language: English
  • Phone: 212-263-5656

About Me

Conditions and Treatments

carotid stenosis, carotid artery disease, arterial occlusive disease, claudication, renal artery stenosis, aortic valve insufficiency, critical limb ischemia, aortic valve stenosis, acute coronary syndrome, mitral valve disease, mitral valve stenosis, heart valve diseases, atrial septal defect (ASD), peripheral vascular disease (PVD), heart attack, mitral regurgitation (MR), aortic valve disease, pulmonary stenosis, peripheral vascular disease (PVD), cardiac catheterization
Show More Conditions

Credentials

Positions
  • Associate Professor, Department of Medicine
  • Dir Card Cath & Interventional Card BV
Board Certifications
  • American Board of Internal Medicine (Interventional Cardiology), 1999
  • American Board of Internal Medicine (Cardiovascular Disease), 1979
  • American Board of Internal Medicine - Internal Medicine, 1976
Education and Training
  • Fellowship, NYU Medical Center, Cardiology, 1978
  • Residency, NYU Medical Center, 1976
  • MD from New York University, 1972
Departments

Locations and Appointments

64 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Cigna EPO/POS
  • Cigna PPO
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Family Health
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • HealthPlus Child Health (Amerigroup)
  • HealthPlus Family Health (Amerigroup)
  • HealthPlus Medicaid (Amerigroup)
  • HealthRepublic
  • HealthSmart (WTC)
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Exchange
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • United Exchange- Compass
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Cardiac Catheterization Associates

550 1st Avenue, 14th Floor
New York, NY 10016

Contact

Phone: 212-263-5656

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

In addition to performing over 2,000 of diagnostic angiography catheterizations, over 500 angioplasties are performed annually at NYU Medical Center. Balloon angioplasty is sometimes followed by restenosis.

Frederick Feit M.D.'s studies are focused on this persistent clinical problem which affects approximately 30 percent of patients within 6 months. Second angioplasties and/or bypass surgeries are the common follow-up procedure to correct restenosis. New procedures such as atherectomy, and implantation of a stent are also being investigated in this laboratory. The long term effectiveness of atherectomy and stents is, however, unknown and far more research in this area needs to be conducted.

Research is underway into the biological basis for restenosis, which is partially due to a biological response or an attempt at healing the damage to the artery that is mediated by growth factors. The blocking of growth factors or genes that stimulate restinosis factors constitute some of the directions of future research, conducted in collaboration with the Medical Center's basic scientists.

Publications

  • Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: Insight from over 8.1 million percutaneous coronary interventions

    Bangalore, Sripal; Gupta, Navdeep; Genereux, Philippe; Guo, Yu; Pancholy, Samir; Feit, Frederick
    International journal of cardiology. 2015 Jan. 183C: 6-10

  • Surgical Versus Percutaneous Coronary Revascularization for Multivessel Disease in Diabetic Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome: Analysis From the Acute Catheterization and Early Intervention Triage Strategy Trial

    Ben-Gal, Yanai; Mohr, Rephael; Feit, Frederick; Ohman, E Magnus; Kirtane, Ajay; Xu, Ke; Mehran, Roxana; Stone, Gregg W
    Circulation: Cardiovascular interventions. 2015 Jun. 8 (6): 219-222

  • Trend in the use of drug eluting stents in the United States: Insight from over 8.1million coronary interventions

    Bangalore, Sripal; Gupta, Navdeep; Guo, Yu; Feit, Frederick
    International journal of cardiology. 2014 May. 336-337

Read All Publications (189)